Centene Corporation (0HVB.L)
USD 59.81
(-0.08%)
USD 59.81
(-0.08%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 138.33 Billion USD | 374.42% |
| 2022 | 29.15 Billion USD | 22.05% |
| 2021 | 23.89 Billion USD | 13.14% |
| 2020 | 21.11 Billion USD | 54.82% |
| 2019 | 13.64 Billion USD | 11.99% |
| 2018 | 12.18 Billion USD | 30.78% |
| 2017 | 9.31 Billion USD | 9.8% |
| 2016 | 8.48 Billion USD | 77.0% |
| 2015 | 4.79 Billion USD | -68.47% |
| 2014 | 15.19 Billion USD | 48.29% |
| 2013 | 10.24 Billion USD | 35.32% |
| 2012 | 7.57 Billion USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 8.28 Billion USD | -6.84% |
| 2024 Q2 | 35.2 Billion USD | 324.86% |
| 2024 Q3 | 9.15 Billion USD | -73.99% |
| 2023 Q3 | 7.35 Billion USD | 4.12% |
| 2023 Q1 | 8.19 Billion USD | 18.17% |
| 2023 FY | 31.49 Billion USD | 7.99% |
| 2023 Q4 | 8.89 Billion USD | 21.01% |
| 2023 Q2 | 7.05 Billion USD | -13.85% |
| 2022 Q2 | 7.27 Billion USD | -8.98% |
| 2022 Q1 | 7.99 Billion USD | 22.14% |
| 2022 Q3 | 6.95 Billion USD | -4.37% |
| 2022 FY | 29.15 Billion USD | 22.05% |
| 2022 Q4 | 6.93 Billion USD | -0.33% |
| 2021 Q3 | 6.14 Billion USD | 6.7% |
| 2021 Q4 | 6.54 Billion USD | 6.42% |
| 2021 FY | 23.89 Billion USD | 13.14% |
| 2021 Q1 | 5.43 Billion USD | -79.45% |
| 2021 Q2 | 5.76 Billion USD | 6.02% |
| 2020 Q2 | 23.7 Billion USD | -0.91% |
| 2020 Q1 | 23.92 Billion USD | 34.67% |
| 2020 Q4 | 26.44 Billion USD | -0.57% |
| 2020 Q3 | 26.59 Billion USD | 12.2% |
| 2020 FY | 21.11 Billion USD | 54.82% |
| 2019 Q2 | 16.65 Billion USD | 3.11% |
| 2019 Q3 | 18.03 Billion USD | 8.3% |
| 2019 FY | 13.64 Billion USD | 11.99% |
| 2019 Q1 | 16.15 Billion USD | 5.84% |
| 2019 Q4 | 17.76 Billion USD | -1.52% |
| 2018 Q2 | 12.38 Billion USD | 3.08% |
| 2018 Q1 | 12.01 Billion USD | 5.29% |
| 2018 Q4 | 15.26 Billion USD | -0.35% |
| 2018 FY | 12.18 Billion USD | 30.78% |
| 2018 Q3 | 15.31 Billion USD | 23.64% |
| 2017 Q4 | 11.41 Billion USD | 2.99% |
| 2017 Q3 | 11.08 Billion USD | 0.71% |
| 2017 Q2 | 11 Billion USD | 0.71% |
| 2017 Q1 | 10.92 Billion USD | 7.62% |
| 2017 FY | 9.31 Billion USD | 9.8% |
| 2016 Q4 | 10.15 Billion USD | 2.82% |
| 2016 FY | 8.48 Billion USD | 77.0% |
| 2016 Q3 | 9.87 Billion USD | -0.26% |
| 2016 Q2 | 9.89 Billion USD | 54.89% |
| 2016 Q1 | 6.39 Billion USD | 13.54% |
| 2015 Q2 | 5.01 Billion USD | 8.18% |
| 2015 FY | 4.79 Billion USD | -68.47% |
| 2015 Q1 | 4.63 Billion USD | 9.87% |
| 2015 Q4 | 5.62 Billion USD | 6.61% |
| 2015 Q3 | 5.28 Billion USD | 5.37% |
| 2014 Q2 | 3.64 Billion USD | 11.15% |
| 2014 Q4 | 4.21 Billion USD | 4.07% |
| 2014 Q3 | 4.05 Billion USD | 11.05% |
| 2014 FY | 15.19 Billion USD | 48.29% |
| 2014 Q1 | 3.28 Billion USD | 18.34% |
| 2013 Q1 | 2.38 Billion USD | 49.33% |
| 2013 FY | 10.24 Billion USD | 35.32% |
| 2013 Q3 | 2.64 Billion USD | 7.83% |
| 2013 Q4 | 2.77 Billion USD | 4.97% |
| 2013 Q2 | 2.45 Billion USD | 2.85% |
| 2012 FY | 7.57 Billion USD | 0.0% |
| 2012 Q4 | 1.59 Billion USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Phreesia, Inc. | 369.84 Million USD | -37304.182% |
| Accuray Incorporated | 142.61 Million USD | -96898.254% |
| Align Technology, Inc. | 2.07 Billion USD | -6560.937% |
| Elevance Health Inc. | 36.23 Billion USD | -281.764% |
| AxoGen, Inc. | 149.33 Million USD | -92534.06% |
| Boston Scientific Corporation | 7.5 Billion USD | -1743.006% |
| CVS Health Corporation | 40.68 Billion USD | -239.992% |
| Cardinal Health, Inc. | 5 Billion USD | -2666.72% |
| DaVita Inc. | 1.47 Billion USD | -9285.177% |
| HCA Healthcare, Inc. | 45.43 Billion USD | -204.443% |
| Hologic, Inc. | 1.26 Billion USD | -10813.222% |
| Humana Inc. | 102.36 Billion USD | -35.145% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -12558.371% |
| Laboratory Corporation of America Holdings | 2.02 Billion USD | -6743.574% |
| Masimo Corporation | 867 Million USD | -15855.709% |
| McKesson Corporation | 8.67 Billion USD | -1494.651% |
| Patterson Companies, Inc. | 1.12 Billion USD | -12171.249% |
| Quest Diagnostics Incorporated | 1.61 Billion USD | -8492.298% |
| ResMed Inc. | 1.36 Billion USD | -10009.524% |
| Henry Schein, Inc. | 2.93 Billion USD | -4610.112% |
| Teladoc Health, Inc. | 2.09 Billion USD | -6515.981% |
| Universal Health Services, Inc. | 9.2 Billion USD | -1402.288% |
| Veeva Systems Inc. | 1.25 Billion USD | -10904.83% |
| Baxter International Inc. | 5.27 Billion USD | -2523.976% |
| Becton, Dickinson and Company | 6.71 Billion USD | -1961.025% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | -4569.254% |
| Danaher Corporation | 8.75 Billion USD | -1480.08% |
| Stryker Corporation | 9.2 Billion USD | -1402.183% |
| Medtronic plc | 16.12 Billion USD | -757.685% |